4/A
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-001613
President and CEO gave up 48,752 shares (to pay taxes)
- President and CEO acquired 213,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2022-01-03 | Grant or award | +150,000 | 916,481 | D | ||
| KIDRON NADAV President and CEO | 2022-01-03 | Shares withheld for taxes | −48,752 | $13.89 | $677,165 | 867,729 | D |
| KIDRON NADAV President and CEO | 2022-01-03 | Grant or award | +63,000 | 930,729 | D | ||
| Derivatives | |||||||
| KIDRON NADAV President and CEO | 2022-01-03 | Grant or award · Stock Option (right to buy | +107,000 | 107,000 | D | ||
Loading xslF345X03/ownership.xml…